Freyr to Provide Regulatory Submission Services for a US Based Biotech Company

Freyr is all geared up to offer its specialized regulatory submissions services to a US based, Medical Instrumentation & Biotech Company.

As part of the project, Freyr will provide end-to-end support for submission of a New Drug Application (NDA) that will require conversion of 3000+ pages of Module I, II, III non-electronic documents to eCTD format in very strict timelines.

Expressing his views on growing demand for critical submission services, Sudheer Sagar, VP Operations, Freyr has said “Today’s businesses demand the highest level of service availability and stability with faster and efficient turn-around times, and Freyr is well-positioned to support client’s on these critical requirements.”